Gilead ups its donation of the Covid-19 drug remdesivir - STAT

Gilead ups its donation of the Covid-19 drug remdesivir - STAT

Gilead ups its donation of the Covid-19 drug remdesivir for U.S. hospitals

By ERIC BOODMAN

ADOBE

Gilead Sciences, the drug company behind the experimental Covid-19 therapy remdesivir, has upped the number of doses it’s donating for U.S. hospitals.

READ MORE